Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Apr 22, 2026
Why Is TE Connectivity (TEL) Stock Down -9% Today?

Why Is TE Connectivity (TEL) Stock Down -9% Today?

Key Takeaways

  • TEL shares dropped approximately 9% in premarket trading on April 22, 2026, falling from a prior close of $247.66 to around $225.37, in an earnings-day selloff despite a headline beat on both EPS and revenue.
  • Q2 FY2026 adjusted EPS came in at $2.73, exceeding the $2.68 analyst consensus by $0.05; revenue of $4.74 billion was essentially in line but fell slightly short of the $4.76 billion expected by more optimistic estimates.
  • Q3 FY2026 guidance topped consensus — management projected ~$5.0 billion in revenue vs. $4.95 billion expected, and adjusted EPS of ~$2.83 vs. $2.79 expected — yet the forward outlook failed to impress a market that had priced in a more emphatic upside surprise.
  • The stock had surged to a 52-week high of $250.67 just one session prior, setting an extremely elevated bar and making a "sell the news" reaction the path of least resistance after an in-line print.
  • Stretched valuation — a P/E ratio of ~35x against a historical median of ~18x — and $9.6 million in insider stock sales over the past three months amplified bearish sentiment in the premarket session.
  • Traders are now watching the earnings call commentary at 8:30 AM ET for guidance detail on tariff exposure, AI revenue acceleration, and transportation segment recovery.

Opening Summary

TE Connectivity plc (TEL) is the world's largest electrical connector supplier, designing and manufacturing connectivity and sensor solutions for transportation, industrial machinery, AI data centers, energy infrastructure, and medical devices. Headquartered in Ireland and operating across more than 150 countries, the company generates annual revenues exceeding $18 billion.

Ahead of the April 22, 2026 regular session open, TEL shares tumbled approximately 9%, dropping from a prior close of $247.66 to around $225.37 in premarket trading. The decline followed the company's release of Q2 FY2026 results before the bell — a report that technically beat estimates on earnings per share and revenue, but delivered a magnitude of outperformance that investors who had driven the stock to near all-time highs found insufficient to justify holding at stretched valuations.

Earnings Beat That Wasn't Enough

TE Connectivity posted Q2 FY2026 adjusted EPS of $2.73, topping the Street's $2.68 consensus by $0.05. Revenue came in at $4.74 billion, nominally above the $4.73 billion consensus but below the $4.76 billion anticipated by more bullish forecasters. CEO Terrence Curtin noted that the company surpassed its own guidance for the quarter, citing double-digit sales growth and record earnings per share.

While those are objectively strong results, the issue is context. TEL had already delivered a 7% EPS beat in Q1 FY2026 — reporting $2.72 vs. a $2.54 consensus — and the stock had been bid up sharply in anticipation of a similarly emphatic Q2 surprise. When the beat landed at just $0.05 per share on a negligible revenue delta, the gap between expectation and reality proved wide enough to trigger an aggressive unwind of pre-earnings long positions.

Record Orders, But the Bar Was Already Priced In

One genuine bright spot in the report was orders: TEL announced a new record of $5.3 billion in orders for the quarter, a 25% increase year over year, driven by surging demand across AI data center infrastructure, advanced transportation, and electrical grid modernization. The company's order book signals healthy revenue visibility into the back half of fiscal 2026.

However, record orders had effectively been telegraphed by prior quarter guidance and analyst previews, meaning the market had already incorporated that optimism into a stock trading near $250. A confirmed record without a dramatic upside guidance revision wasn't enough to sustain the rally, particularly with the stock sitting at a 52-week high and a P/E ratio more than 90% above its long-term historical average.

Valuation Reset Underway

At a trailing P/E of approximately 35x — nearly double the historical median of ~18x — TEL entered earnings as one of the most premium-valued industrial hardware stocks in its peer group. For that valuation to be sustained or expanded, investors needed a clear acceleration: a significant EPS beat, a marked upward revision to full-year guidance, or a dramatic expansion in margin outlook.

The Q2 report provided none of those at a sufficient scale. Instead, investors chose to reprice the stock toward a more defensible valuation level, particularly as broader macro uncertainty — including ongoing tariff risk and a risk-off shift in industrial and technology hardware names — gave them further reason to reduce exposure at elevated prices. Insider selling of $9.6 million in shares over the past three months, with zero reported insider purchases, added to the cautious read on near-term conviction from management insiders.

Q3 Guidance: Above Consensus, But Not a Blowout

Management guided Q3 FY2026 revenue to approximately $5.0 billion — representing 10% year-over-year reported growth and 9% organic growth — above the $4.95 billion analyst consensus. Adjusted EPS guidance of $2.83 for Q3 exceeded the $2.79 estimate, implying 17% year-over-year EPS growth.

On its surface, a guidance beat should have supported the stock. But investors appear to have expected a more substantial raise given the record order book of $5.3 billion and management's prior commentary on AI-driven demand growth. The guidance came in constructive rather than transformative, and in a market where TEL was priced for perfection, "better than expected but not materially so" translated directly into selling pressure.

Market Context and Trading Activity

Premarket volume in TEL surged well above its average daily volume of approximately 2.26 million shares, consistent with a high-conviction earnings reaction. The broader industrial technology sector did not show comparable pressure, indicating this is a stock-specific reset rather than a sector-wide rotation.

Technically, TEL had broken above key resistance in the $243–$247 zone only recently on its run to the $250.67 52-week high. A 9% decline would erase that breakout entirely, pulling shares back toward the $225–$230 support band — a zone where buyers who missed the earlier rally may re-engage. The 50-day moving average sits near the $220 level and represents a deeper support level if selling pressure intensifies at the open.

Trending AI Robots

For traders navigating sharp earnings-driven moves like today's action in TEL, Tickeron's Trending AI Robots page offers a curated view of the platform's highest-performing automated trading bots under current market conditions. Tickeron operates hundreds of AI-powered bots covering thousands of tickers — but only those demonstrating the strongest live performance metrics across their specific strategies and timeframes are featured in the Trending AI Robots section. Bots range across momentum, mean-reversion, and swing-trading styles, varying by risk tolerance, holding period, and traded symbols. Traders looking to systematically manage volatility or capitalize on post-earnings price dislocations may find this resource a valuable starting point for AI-assisted market participation.

What Comes Next for TEL

With Q2 results now digested, the investor conference call at 8:30 AM ET on April 22 will be closely watched for additional color on tariff exposure across TEL's global manufacturing footprint, the trajectory of AI-driven revenue growth, and whether the transportation segment — the company's largest by revenue — is seeing the recovery investors anticipated heading into 2026.

The next formal earnings milestone is Q3 FY2026, expected in late July 2026. Analyst consensus maintains a broadly positive long-term view, with a mean price target of approximately $258–$267 and 14 of 19 analysts holding a Buy rating ahead of the print. Key risks that could deepen the selloff include any escalation in trade tariffs that pressures margins, a slowdown in hyperscaler AI capital expenditure, and further insider selling that could weigh on sentiment in a stock now undergoing a valuation reset.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: TEL

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


TEL in +4.40% Uptrend, advancing for three consecutive days on October 02, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TEL advanced for three days, in 205 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 21, 2026. You may want to consider a long position or call options on TEL as a result. In 55 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.

The Moving Average Convergence Divergence (MACD) for TEL just turned positive on September 21, 2026. Looking at past instances where TEL's MACD turned positive, the stock continued to rise in 22 of 45 cases over the following month. The odds of a continued upward trend are 49%.

TEL moved above its 50-day moving average on September 21, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TEL crossed bullishly above the 50-day moving average on September 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 45%.

The Aroon Indicator entered an Uptrend today. In 110 of 220 cases where TEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 50%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TEL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.

TEL broke above its upper Bollinger Band on September 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 30 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock better than average.

The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.693) is normal, around the industry mean (5.615). P/E Ratio (21.029) is within average values for comparable stocks, (81.453). Projected Growth (PEG Ratio) (0.919) is also within normal values, averaging (1.658). Dividend Yield (0.014) settles around the average of (0.005) among similar stocks. P/S Ratio (3.089) is also within normal values, averaging (4.796).

The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 53 (best 1 - 100 worst), indicating fairly steady price growth. TEL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Corning (NYSE:GLW), Universal Display Corp (NASDAQ:OLED).

Industry description

The Electronic Components industry produces electronic equipment for industries and consumer electronics products, such as mobile devices, televisions, and circuit boards. TE Connectivity Ltd, for example, is a company that designs and manufactures connectivity and sensor products for harsh environments in various industries, such as automotive, industrial equipment, aerospace, and oil & gas. Another major player, Corning Inc., makes advanced optics including end-to-end fiber and wireless solutions for communications networks along with various other technologies catering to industrial and scientific applications.

Market Cap

The average market capitalization across the Electronic Components Industry is 14.08B. The market cap for tickers in the group ranges from 5.86K to 208.67B. APH holds the highest valuation in this group at 208.67B. The lowest valued company is NXOPF at 5.86K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Components Industry was 3%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 17%. OPTX experienced the highest price growth at 38%, while MTEK experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Electronic Components Industry was -23%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 48
Price Growth Rating: 48
SMR Rating: 72
Profit Risk Rating: 65
Seasonality Score: 27 (-100 ... +100)
View a ticker or compare two or three
TEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an electronic components manufacturer

Industry ElectronicComponents

Industry
Electronic Components
Address
Parkmore Business Park West
Phone
+353 91378040
Employees
93000
Web
https://www.te.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.